These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 23427516)
1. Hypohidrosis and hyperthermia during topiramate treatment in children. Incecik F; Hergüner MO; Altunbaşak S Turk J Pediatr; 2012; 54(5):515-8. PubMed ID: 23427516 [TBL] [Abstract][Full Text] [Related]
2. Hypohidrosis-related symptoms in pediatric epileptic patients with topiramate. Kim SC; Seol IJ; Kim SJ Pediatr Int; 2010 Feb; 52(1):109-12. PubMed ID: 19549063 [TBL] [Abstract][Full Text] [Related]
3. Topiramate associated hypohidrosis and hyperthermia. Incecik F; Hergüner MO; Altunbasak S Indian Pediatr; 2008 Mar; 45(3):238-40. PubMed ID: 18367774 [TBL] [Abstract][Full Text] [Related]
4. Symptomatic and asymptomatic hypohidrosis in children under topiramate treatment. Yilmaz K; Tatli B; Yaramiş A; Aydinli N; Calişkan M; Ozmen M Turk J Pediatr; 2005; 47(4):359-63. PubMed ID: 16363346 [TBL] [Abstract][Full Text] [Related]
5. Hypohidrosis induced by topiramate in an adult patient. Karachristianou S; Papamichalis E; Sarantopoulos A; Boura P; Georgiadis G Epileptic Disord; 2013 Jun; 15(2):203-6. PubMed ID: 23773932 [TBL] [Abstract][Full Text] [Related]
6. Hypohidrosis during topiramate treatment: a rare and reversible side effect. Cerminara C; Seri S; Bombardieri R; Pinci M; Curatolo P Pediatr Neurol; 2006 May; 34(5):392-4. PubMed ID: 16648001 [TBL] [Abstract][Full Text] [Related]
7. Oligohydrosis and hyperthermia: pilot study of a novel topiramate adverse effect. Ben-Zeev B; Watemberg N; Augarten A; Brand N; Yahav Y; Efrati O; Topper L; Blatt I J Child Neurol; 2003 Apr; 18(4):254-7. PubMed ID: 12760427 [TBL] [Abstract][Full Text] [Related]
8. Hypohidrosis related to the administration of topiramate to children. Arcas J; Ferrer T; Roche MC; Martínez-Bermejo A; López-Martín V Epilepsia; 2001 Oct; 42(10):1363-5. PubMed ID: 11737174 [TBL] [Abstract][Full Text] [Related]
10. Electrophysiological study in 2 children with transient hypohidrosis induced by topiramate. Margari L; Ventura P; Buttiglione M; Presicci A; Lucarelli E; Sardaro M; Di Fruscolo O; de Tommaso M Clin Neuropharmacol; 2008; 31(6):339-46. PubMed ID: 19050411 [TBL] [Abstract][Full Text] [Related]
11. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of topiramate in children younger than 2 years old. Valencia I; Fons C; Kothare SV; Khurana DS; Yum S; Hardison HH; Legido A J Child Neurol; 2005 Aug; 20(8):667-9. PubMed ID: 16225812 [TBL] [Abstract][Full Text] [Related]
13. [Anhidrosis and hyperthermia associated with treatment with topiramate]. Nieto-Barrera M; Nieto-Jiménez M; Candau R; Ruiz del Portal L Rev Neurol; 2002 Jan 16-31; 34(2):114-6. PubMed ID: 11988904 [TBL] [Abstract][Full Text] [Related]
14. Effect of topiramate on intractable seizures in Taiwanese children. Li ST; Shen EY; Chiu NC; Ho CS Acta Neurol Taiwan; 2004 Jun; 13(2):59-63. PubMed ID: 15478676 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study. Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581 [TBL] [Abstract][Full Text] [Related]